SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-082032
Filing Date
2013-02-28
Accepted
2013-02-28 08:06:15
Documents
4
Period of Report
2013-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d493837d8k.htm 8-K 16303
2 EX-99.1 d493837dex991.htm EX-99.1 428587
3 GRAPHIC g493837g21u88.jpg GRAPHIC 3600
4 GRAPHIC g493837g42w25.jpg GRAPHIC 2184
  Complete submission text file 0001193125-13-082032.txt   454492
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 13649116
SIC: 2834 Pharmaceutical Preparations